IBM, Medtronic Design Cognitive Diabetes Management App | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

IBM, Medtronic Design Cognitive Diabetes Management App

January 8, 2016
by Heather Landi
| Reprints
Click To View Gallery

Medtronic announced they are working on a research prototype smartphone app that will predict hypoglycemic events in diabetes patients up to three hours in advance.

According to a press release from Medtronic, the app is being designed to provide relevant, real-time insights and coaching to help people improve their ability to understand the impact of daily activities on their diabetes and make adjustments as needed, as well as personalized diabetes management by applying Watson’s cognitive computing power to data from Medtronic’s wearable medical devices, including insulin pumps and continuous glucose monitoring devices.

In a pilot study, Medtronic and IBM applied cognitive analytics to 600 anonymous patient cases using data from Medtronic insulin pumps and glucose monitors and the technology was able to predict hypoglycemia – low blood sugar – up to three hours in advance of onset, early enough to enable a diabetes patient to take action to prevent a potentially dangerous health event, according to the Medtronic release.

Also announced at CES 2016, Pathway Genomics, a medical diagnostics company, and IBM have worked together on a genomic wellness app. The OME app, according to a joint release, merges cognitive computing with precision medicine and genetics and will provide consumers with personalized wellness information.

The alpha version of the app incorporates information from Pathway’s FIT Test, a wellness-based diet, exercise and metabolism report compiled with information from the user’s unique genetic traits, as well as their health habits, data from GPS and wearable health monitors and the users Apple HealthKit.

Future versions of the Pathway OME app will enable users to opt-in to include electronic health records, insurance information and additional datasets that will enable OME to provide precise and actionable wellness recommendations, the companies said.

To collect relevant genetic data, after approval by a licensed physician, Pathway Genomics will mail the user a saliva DNA collection kit.  Then, Pathway will work with additional clinicians and scientists to conduct the Pathway Fit genetic test. The Pathway Fit test specifically looks at 75 genes that focus on phenotypes like diet, exercise, lipids and sugar metabolism.

Pathway's OME app then delivers personalized wellness insights to the user based on Pathway Genomics' proprietary analytics of the findings from the genetic test and other user data combined with Watson cognitive computing technology, intelligent machine learning, and a corpus of health and wellness information.

 

 

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.

Analysis: Healthcare Ransomware Attacks Decline in First Half of 2018

In the first half of 2018, ransomware events in major healthcare data breaches diminished substantially compared to the same time period last year, as cyber attackers move on to more profitable activities, such as cryptojacking, according to a new report form cybersecurity firm Cryptonite.